Recent studies have linked the CD244 inhibitory signaling to maintaining an exhausted phenotype in NK- and T-cells in chronic infection (i.e., SARS-CoV-2) and cancer, leading to tumor growth [53,54,55]. Here, CD244 is linked to cancer.